4
Changes in Ownership
WEST PHARMACEUTICAL SERVICES INC Filed Acc 0000105770-26-000110
Sr. VP & Chief HR Officer sold 7,524 shares at an average $355.03 ($2,671,260)
- Sr. VP & Chief HR Officer acquired 7,524 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Favorite Annette F · Sr. VP & Chief HR Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,500 | $89.64 | $224,100 | 24,317.81 | D |
| 2026-09-11 | Sale : show line 2 in the form 10b5-1 | −2,500 | $345.00 | $862,500 | 21,817.81 | D |
| 2026-09-14 | Exercise or conversion : show line 3 in the form 10b5-1 | +2,500 | $89.64 | $224,100 | 24,317.81 | D |
| 2026-09-14 | Sale : show line 4 in the form 10b5-1 | −2,500 | $355.00 | $887,500 | 21,817.81 | D |
| 2026-09-15 | Exercise or conversion : show line 5 in the form 10b5-1 | +2,524 | $89.64 | $226,251 | 24,341.81 | D |
| 2026-09-15 | Sale : show line 6 in the form 10b5-1 | −2,524 | $365.00 | $921,260 | 21,817.81 | D |
| Open-market sales · 7,524 sh · avg $355.03 · $2,671,260 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-11 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −2,500 | 5,024 | D |
| 2026-09-14 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −2,500 | 2,524 | D |
| 2026-09-15 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | −2,524 | 0 | D |
Loading xslF345X06/wk-form4_1789504664.xml…